Evidence map›Paper›PMID 32533341›Full record

ArticleVirchows Archiv : an international journal of pathology2020

Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.

Yusuke Gokon, Fumiyoshi Fujishima, Yusuke Taniyama, Hirotaka Ishida, Taku Yamagata, Takashi Sawai, Miwa Uzuki, Hirofumi Ichikawa, Yuko Itakura, Kazutomi Takahashi and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Yusuke GokonDepartment of Surgery, Tohoku University Hospital, Sendai, Japan.
Fumiyoshi FujishimaDepartment of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. ffujishima@patholo2.med.tohoku.ac.jp.
Yusuke TaniyamaDepartment of Surgery, Tohoku University Hospital, Sendai, Japan.
Hirotaka IshidaDepartment of Surgery, Tohoku University Hospital, Sendai, Japan.
Taku YamagataDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Takashi SawaiDepartment of Pathology, Sendai City Medical Center, Sendai, Japan.
Miwa UzukiDepartment of Medical Science and Welfare, Tohoku Bunka Gakuen University, Sendai, Japan.
Hirofumi IchikawaDepartment of Surgery, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan.
Yuko ItakuraDepartment of Pathology, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan.
Kazutomi TakahashiDepartment of Surgery, Hachinohe City Hospital, Hachinohe, Japan.
Nobuhisa YajimaDepartment of Pathology and Laboratory Medicine, Hachinohe City Hospital, Hachinohe, Japan.
Motohisa HagiwaraDepartment of Surgery, Nihonkai General Hospital, Sakata, Japan.
Akiko NishidaDepartment of Pathology, Nihonkai General Hospital, Sakata, Japan.
Yohei OzawaDepartment of Gastrointestinal Surgery, Iwate Prefectural Central Hospital, Morioka, Japan.
Tsutomu SakumaDepartment of Pathology, Iwate Prefectural Central Hospital, Morioka, Japan.
Rikiya KanbaDepartment of Surgery, Osaki Citizen Hospital, Ōsaki, Japan.
Kazuhiro SakamotoDepartment of Pathology, Osaki Citizen Hospital, Ōsaki, Japan.
Masashi ZuguchiDepartment of Surgery, Hiraka General Hospital, Yokote, Japan.
Masahiro SaitoDepartment of Pathology, Hiraka General Hospital, Yokote, Japan.
Takashi KameiDepartment of Surgery, Tohoku University Hospital, Sendai, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Tohoku University Hospital · JPHachinohe Gakuin University · JPHiraka General Hospital · JPIwate Prefectural Central Hospital · JPNihonkai General Hospital · JPOsaki Citizen Hospital · JPSendai Medical Center · JPTohoku Bunka Gakuen University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune microenvironment plays a pivotal role in cancer development and progression. Therefore, we studied the status of immune cells in esophageal adenocarcinoma (EAC) and adjacent Barrett's esophagus (BE) and their association with the clinical course of patients. We included 87 patients with EAC who underwent surgical resection or endoscopic submucosal dissection. CD3, CD8, Foxp3, p53, and Ki-67 were immunolocalized in EAC and adjacent BE (N = 87) and BE without EAC (N = 13). BE adjacent to EAC exhibited higher CD3+ lamina propria lymphocyte (LPL) numbers than BE without EAC. Abundant Foxp3+ LPLs in BE were associated with dysplasia and increased Ki-67 labeling index (LI) in BE glandular cells and tended to link to aberrant p53 expression. Abundant CD8+ LPLs in adjacent BE were associated with worse prognosis of EAC patients (P = 0.019). Results of our present study firstly revealed the potential influence of the tissue immune microenvironment of BE adjacent to EAC on cancer development and eventual clinical outcome of EAC patients. T cell infiltration could play pivotal roles in facilitating the dysplasia-adenocarcinoma sequence in BE. The number of Foxp3+ T cells is increased at the early stage of carcinogenesis and could help identify patients harboring dysplastic and highly proliferating cells. CD8+ T cells could reflect unfavorable inflammatory response in adjacent tissue microenvironment and help predict worse prognosis of EAC patients.

Indexed as

AdenocarcinomaAgedBarrett EsophagusDisease ProgressionEsophageal MucosaEsophageal NeoplasmsFemaleHumansMaleMiddle AgedTumor MicroenvironmentAdjacent mucosaBarrett’s esophagusEsophageal adenocarcinomaImmunohistochemistryLymphocyteMicroenvironment

Identifiers

PMID32533341
OpenAlexW3035701749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.